Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Seminars in Arthritis and Rheumatism
|
November 13, 2018
Update of screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension
Amber Young, Vivek Nagaraja, Mark Basilious, et al.
ACR Open Rheumatology
|
February 2, 2023
Qualitative Interviews to Assess the Content Validity and Usability of the Electronic Raynaud Diary in Patients with Systemic Sclerosis
Robyn T Domsic, Robin Pokrzywinski, Larissa Stassek, et al.
Journal of Medical Internet Research
|
June 26, 2025
The State of Remote Patient Monitoring for Chronic Disease Management in the United States
Margaret M Paul, Nandita Khera, Praneetha R Elugunti, et al.
Arthritis Research & Therapy
|
June 15, 2021
Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohort
Sara Jaafar, Alain Lescoat, Suiyuan Huang, et al.
Clinical and Experimental Rheumatology
|
February 25, 2026
Shaping the landscape of interstitial lung disease in idiopathic inflammatory myopathies: state of the art, evidence gaps and a need for clinical trials
Daphne Rivero Gallegos, Faye M Pais, Ting-Yuan Lan, et al.
Systematic Reviews
|
June 26, 2026
Defining interstitial lung disease related to idiopathic inflammatory myopathies: a systematic review protocol of the Myositis Clinical Trial Consortium (MCTC)
Konstantinos Triantafyllias, Ramiro Gomez, Jisna Paul, et al.
The Lancet. Rheumatology
|
December 30, 2021
Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial
Lorinda Chung, Cathie Spino, Richard McLain, et al.
ACR Open Rheumatology
|
November 26, 2025
Combining Pirfenidone With Mycophenolate Mofetil for Systemic Sclerosis-Related Interstitial Lung Disease (Scleroderma Lung Study III): An Investigator-Initiated, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
Dinesh Khanna, Cathie Spino, Donald P Tashkin, et al.
Rheumatology (Oxford, England)
|
September 29, 2022
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease
David Roofeh, Kevin K Brown, Ella A Kazerooni, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Seminars in Arthritis and Rheumatism
|
November 13, 2018
Update of screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension
Amber Young, Vivek Nagaraja, Mark Basilious, et al.
ACR Open Rheumatology
|
February 2, 2023
Qualitative Interviews to Assess the Content Validity and Usability of the Electronic Raynaud Diary in Patients with Systemic Sclerosis
Robyn T Domsic, Robin Pokrzywinski, Larissa Stassek, et al.
Journal of Medical Internet Research
|
June 26, 2025
The State of Remote Patient Monitoring for Chronic Disease Management in the United States
Margaret M Paul, Nandita Khera, Praneetha R Elugunti, et al.
Arthritis Research & Therapy
|
June 15, 2021
Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohort
Sara Jaafar, Alain Lescoat, Suiyuan Huang, et al.
Clinical and Experimental Rheumatology
|
February 25, 2026
Shaping the landscape of interstitial lung disease in idiopathic inflammatory myopathies: state of the art, evidence gaps and a need for clinical trials
Daphne Rivero Gallegos, Faye M Pais, Ting-Yuan Lan, et al.
Systematic Reviews
|
June 26, 2026
Defining interstitial lung disease related to idiopathic inflammatory myopathies: a systematic review protocol of the Myositis Clinical Trial Consortium (MCTC)
Konstantinos Triantafyllias, Ramiro Gomez, Jisna Paul, et al.
The Lancet. Rheumatology
|
December 30, 2021
Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial
Lorinda Chung, Cathie Spino, Richard McLain, et al.
ACR Open Rheumatology
|
November 26, 2025
Combining Pirfenidone With Mycophenolate Mofetil for Systemic Sclerosis-Related Interstitial Lung Disease (Scleroderma Lung Study III): An Investigator-Initiated, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
Dinesh Khanna, Cathie Spino, Donald P Tashkin, et al.
Rheumatology (Oxford, England)
|
September 29, 2022
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease
David Roofeh, Kevin K Brown, Ella A Kazerooni, et al.
Page
of 4